{
    "code": "51058233",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=51058233",
    "time": "2020-03-20 03:17:44",
    "許可證字號": "衛部藥製字第058233號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/03\/18",
    "發證日期": "103\/03\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY05105823300",
    "中文品名": "憂散膜衣錠5毫克",
    "英文品名": "Ubixa Film Coated Tablets 5mg",
    "適應症": "思覺失調症及其他明顯有正性及／或負性之精神病，雙極性疾患之躁期發作，預防雙極性疾患之復發。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠AL-AL鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "OLANZAPINE",
    "限制項目": "01國　產 24監視期滿學名藥 62完成溶離率試驗",
    "申請商名稱": "6233063768  聯亞藥業股份有限公司",
    "申請商地址": "新竹縣湖口鄉光復北路45號",
    "主製造廠": [
        {
            "製造廠名稱": "6133061495  聯亞藥業股份有限公司新竹廠",
            "製造廠廠址": "新竹縣湖口鄉中興村光復北路45號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200036800",
            "成分名稱": "OLANZAPINE",
            "含量描述": "",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "錠劑直徑約0.8cm",
        "特殊劑型": "",
        "顏色": "白色錠劑",
        "特殊氣味": "",
        "刻痕": "有",
        "形狀": "圓凸形",
        "標記一": "正面:U02",
        "標記二": "反面:5"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "3964_ubixa_實體外觀_鋁箔-108-03-28(廠商自行上傳).PDF",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058233&Seq=004&Type=10"
        },
        {
            "title": "058233實體外觀_錠劑-108-03-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058233&Seq=003&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Ubixa 5mg 10mg共用仿單-109-02-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058233&Seq=009&Type=9"
        },
        {
            "title": "L396-02_p.02_Leaflet_for_Ubixa_FCT_5mg_20170706-108-03-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058233&Seq=008&Type=9"
        },
        {
            "title": "L396-02_p.01_Leaflet_for_Ubixa_FCT_5mg_20170706-108-03-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058233&Seq=007&Type=9"
        },
        {
            "title": "上傳版_L396-02_Leaflet_for_Ubixa_FCT_5mg_20170706-106-08-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058233&Seq=006&Type=9"
        },
        {
            "title": "058233仿單-104-10-19(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058233&Seq=005&Type=9"
        },
        {
            "title": "3964_ubixa_實體外觀_外盒02-108-03-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058233&Seq=019&Type=8"
        },
        {
            "title": "3964_ubixa_實體外觀_外盒01-108-03-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058233&Seq=018&Type=8"
        },
        {
            "title": "M3964-02_Carton_Ubixa_FCT_5mg_20180208-108-03-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058233&Seq=017&Type=8"
        }
    ]
}